209 results on '"Chapman, Joab"'
Search Results
2. Factor VII, EPCR, aPC Modulators: novel treatment for neuroinflammation
3. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
4. PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy
5. LPS-Induced Coagulation and Neuronal Damage in a Mice Model Is Attenuated by Enoxaparin
6. Thrombin Activity in Rodent and Human Skin: Modified by Inflammation and Correlates with Innervation
7. Retracted: Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro
8. Intrinsic Expression of Coagulation Factors and Protease Activated Receptor 1 (PAR1) in Photoreceptors and Inner Retinal Layers
9. Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems
10. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis
11. Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
12. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome
13. Markers for neural degeneration and regeneration: novel highly sensitive methods for the measurement of thrombin and activated protein C in human cerebrospinal fluid
14. Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule
15. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome
16. Rectracted: Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.
17. Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
18. A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF
19. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology
20. Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease
21. Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers
22. Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block
23. Induction of autoimmune depression in mice by anti–ribosomal P antibodies via the limbic system
24. Decreased hippocampal cell proliferation in mice with experimental antiphospholipid syndrome
25. The role of the APOE genotype in immunomodulation
26. A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis
27. The role of thrombin in the pathogenesis of diabetic neuropathy
28. Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis
29. Pros and cons of a prion-like pathogenesis in Parkinson's disease
30. A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma
31. ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer's Dementia
32. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
33. Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment
34. Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus
35. A Linear Temporal Increase in Thrombin Activity and Loss of Its Receptor in Mouse Brain following Ischemic Stroke
36. Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)
37. Restoring GM1 ganglioside expression ameliorates axonal outgrowth inhibition and cognitive impairments induced by blast traumatic brain injury
38. Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes
39. The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro
40. Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro
41. Neurological Impairment in Experimental Antiphospholipid Syndrome is Associated with increased Ligand Binding to Serotonergic 5-HT1A Receptors
42. The CJD Neurological Status Scale: A New Tool for Evaluation of Disease Severity and Progression in Creutzfeldt - Jakob disease
43. Thrombin regulation of synaptic transmission and plasticity: implications for health and disease
44. Neuropsychiatric lupus: a mosaic of clinical presentations
45. Thrombin induces ischemic LTP (iLTP): implications for synaptic plasticity in the acute phase of ischemic stroke
46. Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever
47. Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study
48. Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
49. 16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus
50. Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.